相关实验视频
Updated: Sep 17, 2025
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
创伤质量改善计划死亡报告系统案例报告:由于血液产品可用性的限制而导致的意外死亡率
Rachel M Russo1, Samuel P Mandell, Aaron R Jensen
1From the US Air Force (R.M.R.); Division of Trauma, Acute Care Surgery and Surgical Critical Care (R.M.R.), University of California Davis School of Medicine, Sacramento, California; Division of Burn, Trauma, Acute and Critical Care Surgery (S.P.M.), UT Southwestern Medical Center, Parkland Health and Hospital System, Dallas, Texas; Department of Surgery (A.R.J.), University of California San Francisco, San Francisco; and UCSF Benioff Children's Hospitals (A.R.J.), Oakland, California.
血液制品的有限供应导致创伤患者意外死亡. 改善血液产品获取的策略可以减少创伤护理中的死亡率.
科学领域:
- 创伤护理质量的提高 创伤护理质量的提高
- 紧急医疗中的患者安全
- 医疗保健系统分析分析
背景情况:
- 创伤质量改善计划死亡报告系统收集了导致意外死亡的罕见事件的数据.
- 对提交的案件的分析确定了导致不利结果的反复出现的主题.
- 血制品等关键资源的有限可用性可能会影响患者的生存.
研究的目的:
- 总结两个与血液制品短缺相关的意外死亡病例.
- 确定并提出减轻血液产品供应延迟的策略.
- 减少全国创伤中心的意外死亡率.
主要方法:
- 对向创伤质量改善计划死亡报告系统提交的匿名病例报告的审查.
- 对案件进行主题分析,重点关注导致意外死亡的事件.
- 根据案例审查的发现,制定缓解策略.
主要成果:
- 确定了两个意外死亡病例,直接归因于血液产品供应有限.
- 延迟获得必要的血液产品是患者结果的关键因素.
- 该研究强调了影响创伤护理中血液产品供应链的系统性问题.
结论:
- 解决血液产品的可用性对于改善创伤患者的生存率至关重要.
- 实施当地战略,确保及时获得血液产品,可以预防死亡.
- 需要在血液制品管理方面进行系统性改进,以降低国家创伤死亡率.
相关概念视频
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:30Venous Thrombosis IV: Nursing Management